vs
Side-by-side financial comparison of Amarin Corp plc (AMRN) and SMARTFINANCIAL INC. (SMBK). Click either name above to swap in a different company.
SMARTFINANCIAL INC. is the larger business by last-quarter revenue ($53.8M vs $45.1M, roughly 1.2× Amarin Corp plc). SMARTFINANCIAL INC. runs the higher net margin — 25.4% vs -23.3%, a 48.7% gap on every dollar of revenue. Over the past eight quarters, SMARTFINANCIAL INC.'s revenue compounded faster (15.4% CAGR vs -18.3%).
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.
SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.
AMRN vs SMBK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $45.1M | $53.8M |
| Net Profit | $-10.5M | $13.7M |
| Gross Margin | — | — |
| Operating Margin | 35.5% | — |
| Net Margin | -23.3% | 25.4% |
| Revenue YoY | 7.0% | — |
| Net Profit YoY | 33.0% | 21.6% |
| EPS (diluted) | — | $0.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $45.1M | $53.8M | ||
| Q4 25 | $49.2M | $53.3M | ||
| Q3 25 | $49.7M | $51.1M | ||
| Q2 25 | $72.7M | $49.2M | ||
| Q1 25 | $42.0M | $46.8M | ||
| Q4 24 | $62.3M | $46.8M | ||
| Q3 24 | $42.3M | $44.2M | ||
| Q2 24 | $67.5M | $40.4M |
| Q1 26 | $-10.5M | $13.7M | ||
| Q4 25 | $-1.2M | $13.7M | ||
| Q3 25 | $-7.7M | $13.7M | ||
| Q2 25 | $-14.1M | $11.7M | ||
| Q1 25 | $-15.7M | $11.3M | ||
| Q4 24 | $-48.6M | $9.6M | ||
| Q3 24 | $-25.1M | $9.1M | ||
| Q2 24 | $1.5M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 31.3% | ||
| Q3 25 | -22.4% | 33.2% | ||
| Q2 25 | -22.0% | 29.0% | ||
| Q1 25 | -39.9% | 29.0% | ||
| Q4 24 | -84.3% | 26.5% | ||
| Q3 24 | -59.5% | 24.3% | ||
| Q2 24 | -0.8% | 25.6% |
| Q1 26 | -23.3% | 25.4% | ||
| Q4 25 | -2.5% | 25.7% | ||
| Q3 25 | -15.6% | 26.8% | ||
| Q2 25 | -19.4% | 23.8% | ||
| Q1 25 | -37.4% | 24.0% | ||
| Q4 24 | -78.0% | 20.6% | ||
| Q3 24 | -59.4% | 20.7% | ||
| Q2 24 | 2.3% | 19.8% |
| Q1 26 | — | $0.81 | ||
| Q4 25 | $0.00 | $0.81 | ||
| Q3 25 | $-0.02 | $0.81 | ||
| Q2 25 | $-0.03 | $0.69 | ||
| Q1 25 | $-0.04 | $0.67 | ||
| Q4 24 | $-0.12 | $0.57 | ||
| Q3 24 | $-0.06 | $0.54 | ||
| Q2 24 | $0.00 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $307.8M | $346.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $562.2M |
| Total Assets | $645.8M | $5.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $307.8M | $346.1M | ||
| Q4 25 | $302.6M | $464.4M | ||
| Q3 25 | $286.6M | $557.1M | ||
| Q2 25 | $298.7M | $365.1M | ||
| Q1 25 | $281.8M | $423.0M | ||
| Q4 24 | $294.2M | $387.6M | ||
| Q3 24 | $305.7M | $192.9M | ||
| Q2 24 | $306.7M | $342.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | — | $7.0M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | — | $9.0M | ||
| Q2 24 | — | $12.7M |
| Q1 26 | — | $562.2M | ||
| Q4 25 | $459.3M | $552.4M | ||
| Q3 25 | $458.9M | $538.4M | ||
| Q2 25 | $464.9M | $519.0M | ||
| Q1 25 | $473.7M | $505.8M | ||
| Q4 24 | $486.2M | $491.3M | ||
| Q3 24 | $531.4M | $489.0M | ||
| Q2 24 | $551.9M | $472.5M |
| Q1 26 | $645.8M | $5.9B | ||
| Q4 25 | $670.8M | $5.9B | ||
| Q3 25 | $659.8M | $5.8B | ||
| Q2 25 | $670.1M | $5.5B | ||
| Q1 25 | $655.7M | $5.4B | ||
| Q4 24 | $685.3M | $5.3B | ||
| Q3 24 | $750.6M | $4.9B | ||
| Q2 24 | $799.9M | $4.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
SMBK
| Net Interest Income | $45.9M | 85% |
| Noninterest Income | $7.9M | 15% |
